« Return to News | R&D Trends | Drug Sponsors

Jubilant, Janssen collaborate on neuroscience development

Thursday, June 30, 2011 01:28 PM

A Jubilant Life Sciences subsidiary has formed an alliance to deliver pre-clinical candidates in the neuroscience field to Belgium’s Janssen Pharmaceutica, according to PharmaTimes.

Bedminster, N.J.-based Jubilant Discovery Services is working with Johnson & Johnson’s Janssen division for an initial three-year period. The alliance will focus on multiple drug targets in neuroscience.

Janssen will transfer certain ongoing efforts on selected drug discovery targets to Jubilant, while Jubilant will contribute research services and deliver pre-clinical candidates to Janssen for possible further development and commercialization.

Jubilant may be eligible for milestones and royalties should Janssen successfully develop and commercialize drug candidates covered by the alliance, Jubilant noted.

The collaboration will draw on Jubilant’s global research network, including a new research facility in the U.S. focused on neuroscience, as well as the company’s India-based research centers.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.